[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$alpmy Graphic](https://lunarcrush.com/gi/w:26/t:$alpmy.png) $alpmy

$ALPMY sees increased creator engagement with positive sentiment, despite low overall mentions. Astellas partners with the Korea Institute of Startup and Entrepreneurship Development.

### About $alpmy
This is a summary of social media activity related to the topic $ALPMY.  

### Insights [#](/topic/$alpmy/insights)
- $alpmy creators is up XXXXX% from the previous week.
- $alpmy mentions is up XXXXX% from the previous week.
- $alpmy Creators hit a high of XX for the day
- $alpmy Creators hit an all time of XX for the day

### Engagements: XXX [#](/topic/$alpmy/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$alpmy/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$alpmy/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXX on 2025-05-19  
**1-Year Low**: X on 2025-07-04  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$alpmy/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$alpmy/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$alpmy/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: XX +87%  
**1 Month**: XX +13%  
**1-Year High**: XX on 2025-05-30  
**1-Year Low**: X on 2025-04-27  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$alpmy/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$alpmy/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$alpmy/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $alpmy in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: X  
**1 Week**: XX +89%  
**1 Month**: XX +64%  
**1-Year High**: XX on 2025-07-19  
**1-Year Low**: X on 2025-04-27  
  
  
### Sentiment: XX% [#](/topic/$alpmy/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$alpmy/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$alpmy/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**1-Year High**: XXX% on 2025-05-11  
**1-Year Low**: XX% on 2025-07-24  

**Most Supportive Themes**
- **Creator Engagement:** (40%) Creator activity is up, with XX unique accounts posting about $ALPMY, showing increased interest from a dedicated group.
- **Positive Sentiment:** (50%) Sentiment is positive at 80%, with the majority of social engagement being neutral, but a significant portion is positive.
  
**Most Critical Themes**
- **Low Mentions:** (10%)  Mentions of $ALPMY are low, indicating a lack of widespread discussion.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %    | Negative | %  |
| ------- | -------- | -  | ------- | -    | -------- | -  |
| X       | X        | X% | XXX     | XXX% | X        | X% |
|         |          |    |         |      |          |    |
| Total   | X        | X% | XXX     | XXX% | X        | X% |
  


**Top assets mentioned**
In the posts about $alpmy in the last XX hours

[Pfizer, Inc. (PFE)](/topic/$pfe)
[Gilead Sciences, Inc. (GILD)](/topic/$gild)
[Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences)
[AstraZeneca PLC (AZN)](/topic/$azn)
[Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls)
[Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr)
[Bristol-Myers Squibb Co (BMY)](/topic/$bmy)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Synthetify (SNY)](/topic/$sny)

**Top topics mentioned**
In the posts about $alpmy in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$pfe](/topic/$pfe), [$4503t](/topic/$4503t), [pfe](/topic/pfe), [$rhhby](/topic/$rhhby), [$gild](/topic/$gild), [gilead sciences](/topic/gilead-sciences), [manat](/topic/manat), [$azn](/topic/$azn), [$apls](/topic/$apls), [$kymr](/topic/$kymr), [$dsnky](/topic/$dsnky), [$bmy](/topic/$bmy), [tak](/topic/tak), [$tak](/topic/$tak), [$srzn](/topic/$srzn), [$regn](/topic/$regn), [$eypt](/topic/$eypt), [$ocul](/topic/$ocul), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$25b](/topic/$25b), [$77m](/topic/$77m), [$sny](/topic/$sny), [$730m](/topic/$730m), [$nrix](/topic/$nrix), [1b](/topic/1b), [$2b](/topic/$2b), [sanofi](/topic/sanofi), [$jnj](/topic/$jnj), [$zlab](/topic/$zlab), [$nvs](/topic/$nvs), [$mgnx](/topic/$mgnx), [$arvn](/topic/$arvn), [johnson johnson](/topic/johnson-johnson), [stocks financial services](/topic/stocks-financial-services), [$bntx](/topic/$bntx), [$lly](/topic/$lly), [$akesf](/topic/$akesf), [$abbv](/topic/$abbv), [$smmt](/topic/$smmt), [$mrk](/topic/$mrk), [eli lilly](/topic/eli-lilly), [investment](/topic/investment), [$bayn](/topic/$bayn), [$gsk](/topic/$gsk), [gsk plc](/topic/gsk-plc), [$jazz](/topic/$jazz), [$cslax](/topic/$cslax), [$sgmo](/topic/$sgmo), [$fold](/topic/$fold), [$1530hk](/topic/$1530hk), [$lyel](/topic/$lyel), [$rvmd](/topic/$rvmd), [$20focus](/topic/$20focus), [$tngx](/topic/$tngx), [$oric](/topic/$oric), [$amgn](/topic/$amgn), [jpmorgan chase](/topic/jpmorgan-chase), [stocks banks](/topic/stocks-banks), [abbv](/topic/abbv), [$mkkgy](/topic/$mkkgy), [$nxtc](/topic/$nxtc), [nrix](/topic/nrix), [$srpt](/topic/$srpt), [$avxs](/topic/$avxs), [$qure](/topic/$qure), [$sldb](/topic/$sldb), [$bold](/topic/$bold), [aav](/topic/aav), [$bmrn](/topic/$bmrn), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$nilsy](/topic/$nilsy), [$aacay](/topic/$aacay), [$brdcy](/topic/$brdcy), [$pdypy](/topic/$pdypy), [$therf](/topic/$therf), [$mrwsy](/topic/$mrwsy), [$rnlsy](/topic/$rnlsy), [$sipry](/topic/$sipry), [$fujhy](/topic/$fujhy), [$xsnx](/topic/$xsnx), [$phot](/topic/$phot), [$crrfy](/topic/$crrfy), [$fnmah](/topic/$fnmah), [$anzby](/topic/$anzby), [$enlay](/topic/$enlay), [$akzoy](/topic/$akzoy), [$dnkey](/topic/$dnkey), [$hocpy](/topic/$hocpy), [$toely](/topic/$toely), [$hkxcy](/topic/$hkxcy), [$poahy](/topic/$poahy), [$dsdvy](/topic/$dsdvy), [$shcay](/topic/$shcay), [$heiny](/topic/$heiny), [$uovey](/topic/$uovey), [$zurvy](/topic/$zurvy), [$szkmy](/topic/$szkmy), [$lvvv](/topic/$lvvv), [$amkby](/topic/$amkby)

### Top Social Posts [#](/topic/$alpmy/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Who will be $SGMO business partner for ST-920 #Fabry $TAK $CSL.AX $PFE $FOLD $AZN $ALPMY $FOLD"  
[@jewcypickle](/creator/x/jewcypickle) on [X](/post/tweet/1946611064264868200) 2025-07-19 16:40:18 UTC XX followers, XXX engagements